Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Hemangiopericytoma (HPC) is a rare tumor, accounting for less than 1% of intracranial tumors. Though it’s notoriously difficult to distinguish HPC from meningioma in pre-op images, HPC presents bone and vascular invasion, high local recurrence and distal metastasis clinically, as a surgically challenging malignancy.